Accountability Support Through Peer-Inspired Relationships and Engagement (ASPIRE) Trial
Launched by STANFORD UNIVERSITY · Sep 26, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The ASPIRE Trial is a research study designed to help young adults who want to cut down on their alcohol consumption. The study will test a text messaging program that encourages support from peers, as well as behavioral tips to change drinking habits. Young adults aged 18 to 25 who have recently been drinking heavily (defined as consuming 4 or more drinks for women and 5 or more drinks for men on at least 2 days in the past month) are invited to participate. Participants must live in the U.S., read English, and own a mobile phone capable of receiving text messages.
If you qualify and choose to participate, you will be placed into one of two groups: one will receive the ASPIRE text messages focusing on peer support, while the other group will receive messages that only focus on changing behaviors. The effectiveness of these messages will be evaluated at 3, 6, and 12 months to see how well they help reduce drinking. It’s important to note that this study is not for those currently enrolled in a four-year college, active military members, pregnant individuals, or anyone receiving treatment for alcohol or substance use disorders. Your involvement could contribute to valuable insights on how to better support young adults in their efforts to drink less.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 18-25 years (verified using date of birth)
- • Lives in the U.S. (based on zip code)
- • English reader (verified based on completing screen)
- • 2+ days with ≧4 standard alcohol drinks for women or ≧5 standard alcohol drinks for men in past month
- • Owns a mobile phone with SMS (verified by texting enrollment procedure)
- Exclusion Criteria:
- • Currently enrolled or past enrollment in a 4-year college
- • Active military
- • Pregnant or pregnancy plans in the next 12-months
- • Prisoner status
- • Current or planned treatment for alcohol or substance use disorder in next 12-months
About Stanford University
Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Palo Alto, California, United States
Patients applied
Trial Officials
Brian Suffoletto, MD
Principal Investigator
Stanford University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported